Filing Details
- Accession Number:
- 0001127602-23-006855
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-23 18:08:28
- Reporting Period:
- 2023-02-21
- Accepted Time:
- 2023-02-23 18:08:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc. | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1812464 | Alexander Aravanis | 5200 Illumina Way San Diego CA 92122 | Svp, Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-21 | 9,292 | $0.00 | 12,214 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-21 | 3,894 | $202.84 | 8,320 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-02-22 | 3,078 | $201.42 | 5,242 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-22 | 2,320 | $202.16 | 2,922 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Shares | Disposition | 2023-02-21 | 9,292 | $0.00 | 9,292 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-01-01 | No | 4 | M | Direct |
Footnotes
- Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020.
- Balance includes 65 shares acquired through Employee Stock Purchase Plan.
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 3,078 shares sold ranging from $200.88 to $201.85 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 2,320 shares sold ranging from $201.89 to $202.65 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
